|
Re: Gordon Research Conference
|
6
|
Resverlogix Corp.
|
May 30, 2019 05:02AM
|
|
Re: Accuracy
|
6
|
Resverlogix Corp.
|
Dec 21, 2016 12:04AM
|
|
Re: No mention of efficacy again...
|
6
|
Resverlogix Corp.
|
Mar 29, 2019 01:05PM
|
|
Re: So I was able to finally set up a one on one meeting with...
|
6
|
Resverlogix Corp.
|
Mar 14, 2022 02:49PM
|
|
Re: Private placement
|
6
|
Resverlogix Corp.
|
Aug 30, 2018 09:54AM
|
|
Re: Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes
|
6
|
Resverlogix Corp.
|
Sep 13, 2021 10:22PM
|
|
Re: Something "Material" is happening
|
6
|
Resverlogix Corp.
|
Mar 15, 2021 05:03PM
|
|
Re: New Share Price Contest
|
6
|
Resverlogix Corp.
|
Oct 11, 2019 02:45AM
|
|
Re: Spike
|
6
|
Resverlogix Corp.
|
Sep 09, 2018 01:36PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
6
|
Resverlogix Corp.
|
May 22, 2022 01:44PM
|
|
Re: CANTOS and CIRT
|
6
|
Resverlogix Corp.
|
Nov 13, 2017 04:26PM
|
|
Re: BETonMACE top line data
|
6
|
Resverlogix Corp.
|
Jan 16, 2018 12:58AM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
6
|
Resverlogix Corp.
|
Nov 02, 2020 01:14PM
|
|
Re: pfizer
|
6
|
Resverlogix Corp.
|
Dec 16, 2020 01:44PM
|
|
Re: What is Mr. Market saying about RVX?
|
6
|
Resverlogix Corp.
|
Nov 26, 2018 11:39AM
|
|
Re: This late June meeting, warrants about to expire???
|
6
|
Resverlogix Corp.
|
Apr 12, 2021 01:36PM
|
|
Re: Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink
|
6
|
Resverlogix Corp.
|
Dec 04, 2017 11:34AM
|
|
Re: New Frontiers for both RVX/Zenith
|
6
|
Resverlogix Corp.
|
Apr 20, 2017 06:22PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Jan 16, 2018 09:22AM
|
|
Re: Bear
|
6
|
Zenith Epigenetics
|
Apr 22, 2020 01:43PM
|
